ShareSpot

Short Bites: The Association between Oral Hygiene and Heart Disease

The emergence of chronic disease complications in controlled HIV disease has changed the landscape of HIV clinical care. HIV infection confers an increased cardiovascular disease risk which is thought to be due to a complex interplay of mechanistic factors. While traditional cardiovascular risk fact...

AETC IPE Programs Prepare the Next Generation of HIV Providers

Cross-posted from TargetHIV coverage of the 2018 National Ryan White Conference.

Regional AETCs across the United States are working to bring new clinicians into the HIV workforce through inter-professional education (IPE) programs. IPE trains learners in teams in clinical settings where trainees lea...

Alan
Gambrell
TargetHIV: Tools for HRSA's Ryan White HIV/AIDS Program

The LATITUDE to Stay On Track: NIH to Launch Study in People Non-Adherent to Daily Treatment

Taking effective HIV medications as prescribed offers many benefits for people with HIV—life expectancy normalizes and viral loads drop below detectable levels, preventing the risk of sexual transmission in those who achieve and maintain durable viral suppression. Unfortunately, many individuals fac...

Karin
Klingman
National Institutes of Health
Tia
Morton
National Institutes of Health

Sexual Assault: PEP is an Urgent Health Need

When a patient presents to your emergency department, urgent care or clinic with a chief complaint of sexual assault within the last 24 hours, the challenge is recognizing that, along with safety and criminal justice concerns, this patient has emergent health needs. One of the most urgent of these i...

Diane
Daiber

Short Bites: HIV in the Southeast United States

Southern states today account for an estimated 44 percent of all people with an HIV diagnosis in the U.S.,[1] despite having only about one-third (37%) of the overall U.S. population. Diagnosis rates for people in the South are higher than for Americans overall. Eight of the 10 states with the highe...

Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy

Although DTG currently is not a desirable medication for women to take pre-conception (see Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects), findings from the DolPHIN study suggest that it may be a very useful agent for women who start ART during late pregnancy. The...

Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects

Integrase inhibitors have become primary treatment for most people with HIV; however, the impact of newer integrase inhibitors on pregnancy outcomes has not been well described. Researchers for the observational Tsepamo study have been examining birth outcomes in Botswanan women treated with various...

TargetHIV: New Name, New Look

It's easier than ever to stay on target. The Health Resources and Services Administration's (HRSA) Ryan White HIV/AIDS Program (RWHAP) technical assistance (TA) and training website has undergone a major update to make it easier for users to access tools and materials for the RWHAP. The website, for...

Practicing Cultural Humility to Transform Health Care

Moving beyond culture competency to cultural humility acknowledges patients’ authority over their own lived experience

Health care delivery often involves a one-size-fits-all approach. As clinicians, we treat a patient with a particular diagnosis similar to the last patient we saw with the same diagn...

Jennifer
McGee-Avila

Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study

The EMERALD Study is a Phase III, open-label, noninferiority study in which 1,141 patients with stable HIV suppression on a regimen comprising a boosted protease inhibitor plus TDF/FTC were randomized (2:1) to either switch to an investigational single-tablet regimen containing darunavir 800 mg/cobi...